IGF1 and Duchenne muscular dystrophy: In a clinical trial, patients with Duchenne muscular dystrophy given synthetic IGF-1 for 6 months demonstrated enhanced growth as compared to non-IGF-1-treated patients but did not exhibit improved walking distance [49].